Sonova has now written down its Consumer Hearing business by about CHF 107m in six months. CEO Eric Bernard insists the divestment is strategic and “very much on track.”
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a corporate financial restructuring event with no direct impact on clinical practice.
Sonova's accelerating write-down of its Consumer Hearing unit signals a major strategic retreat from the over-the-counter and consumer audio segment, which could reshape the competitive landscape for hearing care professionals.
- 01Sonova took an additional CHF 68m impairment on its Consumer Hearing business, bringing the six-month total to ~CHF 107m.
- 02CEO Eric Bernard confirmed the planned divestment of the Consumer Hearing unit remains on track.
- 03The write-down reflects declining assessed value of the consumer-facing division ahead of sale.
- 04This move signals Sonova is refocusing on its core professional/clinical hearing aid business.
- 05The divestment could affect OTC and consumer hearing product availability in affected markets.
Sonova has written down its Consumer Hearing business by approximately CHF 107m over six months.
press releasesupportedThe planned divestment of Sonova's Consumer Hearing unit remains on track, according to CEO Eric Bernard.
quotesupported